Dergiler / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 6

How to improve the management of a patient with heparin-induced thrombocytopenia?

Sayfa
339–339
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

I read with keen interest the case report describing a fatal case of probable HIT in a young man who experienced pulmonary embolism (PE) and concomitant deep veinthrombosis (2).

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by immunoglobulin G platelet-activating antibodies against platelet factor 4 (PF4)/heparin complexes, leading to venous and arterial thromboembolism (1).
📊
Temel Bulgular & Veri:Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by immunoglobulin G platelet-activating antibodies against platelet factor 4 (PF4)/heparin complexes, leading to venous and arterial thromboembolism (1).
💡
Sonuç & Katkı:I read with keen interest the case report describing a fatal case of probable HIT in a young man who experienced pulmonary embolism (PE) and concomitant deep veinthrombosis (2).
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by immunoglobulin G platelet-activating antibodies against platelet factor 4 (PF4)/heparin complexes, leading to venous and arterial thromboembolism (1). I read with keen interest the case report describing a fatal case of probable HIT in a young man who experienced pulmonary embolism (PE) and concomitant deep veinthrombosis (2).

🔖

Bu Makaleye Atıf Yap

UNDAS, A. (2019). How to improve the management of a patient with heparin-induced thrombocytopenia?. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 6, 339–339. https://ajindex.com/articles/366806

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2018; 2: 3360-92
  2. Güner A, Avcı A, Uslu A, Kalkan S, Özkan M. Mitral valve and right ventricular thrombi possibly caused by heparin-induced thrombocytopenia. Anatol J Cardiol 2019; 22: 206-9
  3. Douketis J, Ageno W, Carrier M, Kearon C. Managing challenging patients with venous thromboembolism: a practical, case-based approach. Pol Arch Intern Med 2017; 127: 41-6
  4. Bryk AH, Mazur P, Zdziarska J, Kuczia P, Plens K, Leśniak-Sobelga A, et al. Similar prevalence of platelet factor 4/heparin immunoglobulin G antibodies in patients following cardiac surgery and other patients suspected of heparin-induced thrombocytopaenia. Kardiol Pol 2018; 76: 1372-5
  5. Chao CH, Wang HY, Kao CH. Occult cancer and thromboembolism: current epidemiology and its practical implications. Pol Arch Intern Med 2018; 128: 539-44.